Pipex Company Profile

19:40 EST 9th December 2018 | BioPortfolio

Pipex Pharmaceuticals, Inc. (“Pipex”) (OTC: BB: PPEX) is a development-stage, specialty pharmaceutical company that is developing proprietary, late-stage drug candidates for the treatment of neurologic and autoimmune diseases. Our strategy is to exclusively in-license proprietary, clinical-stage drug candidates that have demonstrated clinical efficacy and to complete the further clinical testing and manufacturing sufficient to seek marketing authorizations via the filing of new drug applications (NDAs) with the FDA and marketing application authorizations (MAAs) with the European Medicines Evaluation Agency (EMEA). A key component of our strategy encompasses the efficient and timely development of our clinical-stage drug candidates through the selection of initial indications representing high unmet medical needs and which may therefore benefit from an expeditious regulatory approval process. Once approved, these drug candidates may then be expanded into additional therapeutic indications through additional post-approval clinical trials and supplemental NDA (sNDA) filings. Our lead drug candidate, COPREXA™, is a novel, oral, anti-copper therapeutic that has completed two pivotal phase III clinical trials in neurologically-presenting Wilson’s disease. Based upon FDA communication, we believe that the results of these clinical trials demonstrated sufficient clinical safety and efficacy to support the filing of an NDA in the U.S. for this initial indication. We are currently conducting additional phase II clinical trials of COPREXA™ in order to expand the potential post-approval therapeutic utility of COPREXA™ into additional therapeutic indications, such as idiopathic pulmonary fibrosis (IPF) and other copper mediated neurodegenerative diseases.


3985 Research Park Drive
Ann Arbor
United States of America


Phone: (734) 332-7800
Fax: (734) 332-7878

News Articles [0 Results]


Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [1 Associated Companies listed on BioPortfolio]


Pipex Pharmaceuticals, Inc. (“Pipex”) (OTC: BB: PPEX) is a development-stage, specialty pharmaceutical company that is developing proprietary, late-stage drug candidates for the treatment of neuro...

More Information about "Pipex" on BioPortfolio

We have published hundreds of Pipex news stories on BioPortfolio along with dozens of Pipex Clinical Trials and PubMed Articles about Pipex for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pipex Companies in our database. You can also find out about relevant Pipex Drugs and Medications on this site too.

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record